Psychopharmacology of ADHD in pediatrics: current advances and issues

Review

(3742) Views  (1227) Full article downloads

Authors: Donald E Greydanus, Ahsan Nazeer, Dilip R Patel

Published Date March 2009 Volume 2009:5 Pages 171 - 181

DOI: http://dx.doi.org/10.2147/NDT.S4075

Donald E Greydanus, Ahsan Nazeer, Dilip R Patel

Michigan State University College of Human Medicine, Michigan State University/Kalamazoo Center for Medical Studies, Kalamazoo, MI, USA

Abstract: Attention deficit hyperactivity disorder (ADHD) is a neurobehavioral developmental disorder found in 3% to 8% of children and adolescents. An important part of ADHD management is psychopharmacology, which includes stimulants, norepinephrine reuptake inhibitors, alpha-2 agonists, and antidepressants. Medications with the best evidence-based support for ADHD management are the stimulants methylphenidate and amphetamine. A number of newer, long-acting stimulants are now available and a number of new medications are considered that are under current research.

Keywords: ADHD, methylphenidate, amphetamine, norepinephrine reuptake inhibitors, alpha-2 agonists, antidepressants

Other articles by Professor Donald Greydanus